Imaging agent developer ImaginAb has signed a master service agreement with Singapore Radiopharmaceuticals, a subsidiary of Fortis Healthcare.
The agreement represents part of the company's expansion program in Singapore as it establishes R&D and preclinical imaging capabilities there, according to the firm.
ImaginAb's technology enables antibodies to be re-engineered into smaller proteins with kinetics suitable for diagnostic imaging, the company said.
